Skip to main content

Verisk Analytics, Inc.

For the period ended Jun 30, 2025. Filed Jul 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Jul 30, 2025

VRSK$204.59-3.3%Stored close · as of Nov 6, 2026

What changed in Management’s Discussion and Analysis?

Read the current filing

Previous report: 10-Q

Period ended 2025-03-31; filed 2025-05-07.

0001437749-25-014907

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Current report: 10-Q

Period ended 2025-06-30; filed 2025-07-30.

0001437749-25-023862

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 69 previous paragraphs and 100 current paragraphs.

46 unchanged; 17 reworded; 32 added; 6 removed; 0 previous and 5 current paragraphs rearranged.

Tables are not compared: 10 previous and 11 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (32)

Current report

Revenues were $772.6 million for the three months ended June 30, 2025, compared to $716.8 million for the three months ended June 30, 2024, an** **increase of $55.8 million or 7.8%. Our underwriting revenue increased $42.1 million or 8.3%. Our claims revenue increased $13.7 million or 6.6%.

Current report

Net gain on early extinguishment of debt was $3.6 million for the three months ended June 30, 2024 due to a cash tender offer of $400.0 million aggregate principal amount of our 2025 Senior Notes that was completed on June 7, 2024.

Current report

Investment gain was $9.1 million for thethree months ended June 30, 2025 compared to $99.8 million for thethree months ended June 30, 2024, adecrease of $90.7 million. The decrease was primarily due to the net gains realized in the prior year associated with the settlement of retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022, partially offsetby the impact of foreign currencies associated with transactions in the normal course of business.

Current report

Net income was $253.3 million for the three months ended June 30, 2025 compared to $307.8 million for the three months ended June 30, 2024. The net income margin was 32.8% for thethree months ended June 30, 2025 compared to 42.9% for thethree months ended June 30, 2024. The decrease in net income margin was primarily driven by net gains realized in the prior year associated with the settlement of retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022, and a net gain on the early extinguishment of debt in the prior year, partially offset by the impact of foreign currencies associated with transactions in the normal course of business.

Current report

EBITDA was $ 445.7 million for the three months ended June 30, 2025 compared to $ 499.3 million for the three months ended June 30, 2024. The EBITDA margin for our consolidated results was 57.7% for the three months ended June 30, 2025 compared to 69.7% for the three months ended June 30, 2024. The decrease in EBITDA margin was primarily driven by net gains realized in the prior year associated with the settlement of retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022, and a net gain on the early extinguishment of debt in the prior year, partially offset by the impact of foreign currencies associated with transactions in the normal course of business.

Current report

Six Months Ended June 30, 2025*** Compared to***Six Months Ended June 30, 2024

Current report

Revenues were $1,525.6 million for the six months ended June 30, 2025, compared to $1,420.8 million for the six months ended June 30, 2024, an** **increase of $104.8 million or 7.4%. Our underwriting revenue increased $75.7 million or 7.5%. Our claims revenue increased $29.1 million or 7.0%.

Current report

Cost of revenues was $460.3 million for thesix months ended June 30, 2025 compared to $447.2 million for thesix months ended June 30, 2024, anincreaseof $13.1 million or 2.9%. Our recent acquisition and disposition accounted for a decrease of$6.3 million in cost of revenues. The remaining increase of $19.4 million or 4.4% was primarily due tosalaries and employee benefits of $12.0 million, information technology expenses of $5.5 million, and bad debt expense of $5.0 million, partially offset bya reduction inprofessional consulting fees of $1.6 million, rent expense of $0.3 million, and other operating costs of $1.2 million.

Current report

Selling, general and administrative expenses were $215.4 million for thesix months ended June 30, 2025 compared to $194.4 million for thesix months ended June 30, 2024, an increase of $21.0 million or 10.8%. Our recent acquisition and disposition accounted for a decrease of $1.8 million in selling, general, and administrative expenses. The remaining increase of $22.8 million or 11.9% was primarily due tosalaries and employee benefits of $10.9 million, professional consulting fees of $7.0 million, information technology expense of $1.9 million, rent expense of $1.8 million, and travel expenses of $1.5 million, partially offset by a reduction in insurance expense of $0.3 million.

Current report

Depreciation and amortization of fixed assets were $133.4 million for thesix months ended June 30, 2025 compared to $116.4 millionfor thesix months ended June 30, 2024, anincrease of $17.0 million or 14.6%. The increase was primarily due to internally developed software projects that were completed and placed into service.

Current report

Amortization of intangible assets was $32.1 million for thesix months ended June 30, 2025 compared to $36.7 millionfor thesix months ended June 30, 2024, adecrease of $4.6 million or 12.5%. The decrease was primarily due to intangible assets that were fully amortized of $4.9 million, partially offset by the amortization of intangible assets related to our recent acquisitions of $0.3 million.

Current report

Net gain on early extinguishment of debt was $3.6 million for the six months ended June 30, 2024 due to a cash tender offer of $400.0 million aggregate principal amount of our 2025 Senior Notes that was completed on June 7, 2024.

Current report

Investment gain was $11.7 million for thesix months ended June 30, 2025 compared to $96.5 million for thesix months ended June 30, 2024, adecrease of $84.8 million. The decrease was primarily due to the net gains realized in the prior year associated with the settlement of retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022, partially offset by the impact of foreign currencies associated with transactions in the normal course of business.

Current report

Interest expense, net was $71.8 million for thesix months ended June 30, 2025 compared to $58.0 million for thesix months ended June 30, 2024, an increase of $13.8 million or 23.8%. The increase was primarily driven by interest expense related to the issuance of our 2035 Senior Notes, partially offset by the repayment of our 2025 Senior Notes and increased interest income for the six months ended June 30, 2025.

Current report

Net income was $485.6 million for the six months ended June 30, 2025 compared to $527.2 million for the six months ended June 30, 2024. The net income margin was 31.8% for thesix months ended June 30, 2025 compared to 37.1% for thesix months ended June 30, 2024. The decrease in net income margin was primarily driven by net gains realized in the prior year associated with the settlement of retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022, and a net gain on the early extinguishment of debt in the prior year, partially offset by the impact of foreign currencies associated with transactions in the normal course of business.

Current report

EBITDA was $ 861.6 million for the six months ended June 30, 2025 compared to $ 879.3 million for the six months ended June 30, 2024. The EBITDA margin for our consolidated results was 56.5% for the six months ended June 30, 2025 compared to 61.9% for the six months ended June 30, 2024. The decrease in EBITDA margin was primarily driven by net gains realized in the prior year associated with the settlement of retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022, and a net gain on the early extinguishment of debt in the prior year, partially offset by the impact of foreign currencies associated with transactions in the normal course of business.

Current report

Net cash used in investing activities of$80.6 million for thethree months ended June 30, 2025 wasprimarily related to capital expenditures of$55.8 millionand acquisitions of $20.3 million. Net cash provided by investing activities of$56.1 million for thethree months ended June 30, 2024 wasprimarily related to proceeds received upon settlement of our retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022 of $112.1 million, partially offset by capital expenditures of $57.8 million.

Current report

Net cash used in financing activities of$225.7 million for the six months ended June 30, 2025 was primarily driven bythe repayment of our 2025 senior note of $500.0 million, repurchases of common stock of $300.1 million, dividends paid of $126.0 million, the net share settlement of taxes from restricted stock and performance share awards of $25.5 million, payment of excise tax of $7.6 million, payment of debt issuance costs of $6.2 million, and other financing activities of $6.2 million, partially offset by the proceeds from issuance of long term debt of $698.3 million and proceeds from stock options exercised of $47.6 million. Net cash used in financing activities of$236.9 million for the six months ended June 30, 2024 was primarily driven by the payment on the early extinguishment of debt of $396.4 million, the funding of $350.0 million of accelerated share repurchase programs, and dividends paid of $111.3 million, partially offset by proceeds from the issuance of long-term debt, net of original discount, of $590.2 million, and proceeds from stock options exercised of $63.2 million.
Removed paragraphs (6)

Previous report

Revenues were $753.0 million for the three months ended March 31, 2025, compared to $704.0 million for the three months ended March 31, 2024, a n** **increase o f $49.0 million or 7.0% . Our underwriting revenue increased$33.6 million or 6.8% . Our claims revenue increased $15.4 million or 7.5% .

Previous report

Investment gain was$2.6 million for thethree months ended March 31, 2025 compared to a loss of$3.3 million for thethree months ended March 31, 2024, anincrease of$5.9 million. The increase was primarily driven by the impact of foreign currencies associated with transactions in the normal course of business.

Previous report

Net income was $232.3 million for thethree months ended March 31, 2025 compared to $219.4 million for thethree months ended March 31, 2024. The net income margin was 30.8% for thethree months ended March 31, 2025 compared to 31.2% for thethree months ended March 31, 2024. The decrease in net income margin was primarily driven an increase in our effective tax rate and an increase in interest expense, discussed above.

Previous report

EBITDA was $415.9 million for thethree months ended March 31, 2025 compared to $380.0 million for thethree months ended March 31, 2024. The EBITDA margin for our consolidated results was 55.2% for thethree months ended March 31, 2025 compared to 54.0% for thethree months ended March 31, 2024. The increase in EBITDA margin was primarily driven by revenue growth and cost discipline.
Reworded paragraphs (17)

Previous wording

We earn revenues through agreements for hosted subscriptions, advisory/consulting services, and for transactional solutions, recurring and non-recurring. Subscriptions for our solutions are generally paid in advance of rendering services either quarterly or in full upon commencement of the subscription period, which is usually for one year and automatically renewed each year. As a result, the timing of our cash flows generally precedes our recognition of revenues and income and our cash flow from operations tends to be higher in the first quarter as we receive subscription payments. Examples of these arrangements include subscriptions that allow our customers to access our standardized coverage language, our claims fraud database, or our actuarial services throughout the subscription period. In general, we experience minimal revenue seasonality within the busi ness. For thethree months ended March 31, 2025 and 2024, approximately 83% and 80% of our insurance revenues were derived from hosted subscriptions through agreements (generally one to five years) for our solutions, respectively.

Current wording

We earn revenues through agreements for hosted subscriptions, advisory/consulting services, and for transactional solutions, recurring and non-recurring. Subscriptions for our solutions are generally paid in advance of rendering services either quarterly or in full upon commencement of the subscription period, which is usually for one year and automatically renewed each year. As a result, the timing of our cash flows generally precedes our recognition of revenues and income and our cash flow from operations tends to be higher in the first quarter as we receive subscription payments. Examples of these arrangements include subscriptions that allow our customers to access our standardized coverage language, our claims fraud database, or our actuarial services throughout the subscription period. In general, we experience minimal revenue seasonality within the busi ness. For thesix months ended June 30, 2025 and 2024, approximately 83% and 81% of our insurance revenues were derived from hosted subscriptions through agreements (generally one to five years) for our solutions, respectively.

Previous wording

We also provide advisory/consulting services, which help our customers get more value out of our analytics and their subscriptions. In addition, certain of our solutions are paid for by our customers on a transactional basis, recurring and non-recurring. For example, we have solutions that allow our customers to access property-specific rating and underwriting information to price a policy on a commercial building, or compare a P&C insurance or a workers' compensation claim with information in our databases, or use our repair cost estimation solutions on a case-by-case basis. For thethree months ended March 31, 2025 and 2024, approximately 17% and 20% of our insurance revenues were derived from providing transactional and advisory/consulting solutions, respectively.

Current wording

We also provide advisory/consulting services, which help our customers get more value out of our analytics and their subscriptions. In addition, certain of our solutions are paid for by our customers on a transactional basis, recurring and non-recurring. For example, we have solutions that allow our customers to access property-specific rating and underwriting information to price a policy on a commercial building, or compare a P&C insurance or a workers' compensation claim with information in our databases, or use our repair cost estimation solutions on a case-by-case basis. For thesix months ended June 30, 2025 and 2024, approximately 17% and 19% of our insurance revenues were derived from providing transactional and advisory/consulting solutions, respectively.

Previous wording

Personnel expenses are the major component of both our cost of revenues and selling, general and administrative expenses. Personnel expenses, which represented approximately 56% and 58% of our total operating expenses (excluding gains/losses related to dispositions) for thethree months ended March 31, 2025 and 2024, respectively, include salaries, benefits, incentive compensation, equity compensation costs, sales commissions, employment taxes, recruiting costs, and outsourced temporary agency costs.

Current wording

Personnel expenses are the major component of both our cost of revenues and selling, general and administrative expenses. Personnel expenses, which represented approximately 56% and 58% of our total operating expenses (excluding gains/losses related to dispositions) for the six months ended June 30, 2025 and 2024, respectively, include salaries, benefits, incentive compensation, equity compensation costs, sales commissions, employment taxes, recruiting costs, and outsourced temporary agency costs.

Previous wording

Cost of revenues was $230.8 million for thethree months ended March 31, 2025 compared to$227.8 million for thethree months ended March 31, 2024, anincreaseof$3.0 million or 1.3%. Our recent acquisition and disposition accounted for a decrease of$3.7 million in cost of revenues. The remaining increase of $6.7 million or 3.0% was primarily due toincreasein information technology expenses of $3.4 million, salaries and employee benefits of $3.3 million, bad debt expense of $2.3 million, data costs of $1.0 million, and other operating costs of $0.4 million, partially offset bya reduction inprofessional consulting fees of $2.8 million and rent expense of $0.9 million.

Current wording

Cost of revenues was $229.5 million for thethree months ended June 30, 2025 compared to $219.4 million for thethree months ended June 30, 2024, anincreaseof $10.1 million or 4.6%. Our recent acquisition and disposition accounted for a decrease of$2.6 million in cost of revenues. The remaining increase of $12.7 million or 5.9% was primarily due to salaries and employee benefits of $8.7 million, bad debt expense of $2.8 million, information technology expenses of $2.1 million, professional consulting fees of $1.3 million, and rent expense of $0.6 million, partially offset bya reduction indata costs of $1.0 million, and other operating costs of $1.8 million.

Previous wording

Selling, general and administrative expenses were$108.9 million for thethree months ended March 31, 2025 compared to$92.9 million for thethree months ended March 31, 2024, an increaseof$16.0 million or 17.2%. Our recent acquisition and disposition accounted for a decrease of $0.8 million in selling, general, and administrative expenses. The remaining increase of $16.8 million or 18.3% was primarily due toprofessional consulting fees of $9.2 million, salaries and employee benefits of $4.8 million, travel expenses of $0.8 million, rent expense of $0.8 million, information technology expense of $0.5 million, insurance expense of $0.4 million, and other operating costs of $0.3 million.

Current wording

Selling, general and administrative expenses were $106.5 million for thethree months ended June 30, 2025 compared to $101.5 million for thethree months ended June 30, 2024, an increaseof $5.0 million or 4.9%. Our recent acquisition and disposition accounted for a decrease of $1.0 million in selling, general, and administrative expenses. The remaining increase of $6.0 million or 6.1% was primarily due tosalaries and employee benefits of $6.1 million, information technology expense of $1.4 million, rent expense of $1.0 million, and travel expenses of $0.6 million, partially offset by professional consulting fees of $2.1 million, insurance expense of $0.7 million, and other operating costs of $0.3 million.

Previous wording

Depreciation and amortization of fixed assets were$67.4 million for thethree months ended March 31, 2025 compared to $57.4 millionfor thethree months ended March 31, 2024, anincrease of$10.0 million or 17.4%. The increase was primarily due to the timing of certain large internally developed software projects that were placed into service during 2024 and the first quarter of 2025.

Current wording

Depreciation and amortization of fixed assets were $66.0 million for thethree months ended June 30, 2025 compared to $59.0 millionfor thethree months ended June 30, 2024, anincrease of $7.0 million or 11.9%. The increase was primarily due to internally developed software projects that were completed and placed into service.

Previous wording

Amortization of intangible assets was$15.8 million for thethree months ended March 31, 2025 compared to$18.5 millionfor thethree months ended March 31, 2024, adecrease of$2.7 million or 14.6%. The decrease was primarily due to intangible assets that were fully amortized.

Current wording

Amortization of intangible assets was $16.3 million for thethree months ended June 30, 2025 compared to $18.2 millionfor thethree months ended June 30, 2024, adecrease of $1.9 million or 10.4%. The decrease was primarily due to intangible assets that were fully amortized.

Previous wording

Interest expense, net was$36.3 million for thethree months ended March 31, 2025 compared to $28.9 million for thethree months ended March 31, 2024, anincrease of$7.4 million or 25.6%. The increase was primarily driven by interest expense related to the issuance of our 2034 and 2035 Senior Notes, partially offset by higher interest income for the three months ended March 31, 2025.

Current wording

Interest expense, net was $35.5 million for thethree months ended June 30, 2025 compared to $29.1 million for thethree months ended June 30, 2024, anincrease of$6.4 million or 22.0%. The increase was primarily driven by interest expense related to the issuance of our 2035 Senior Notes, partially offset by the repayment of our 2025 Senior Notes and higher interest income for the three months ended June 30, 2025.

Previous wording

The provision for income taxes was$64.1 million and the effective tax rate was 21.6% for thethree months ended March 31, 2025, compared to$55.8 million and 20.3% for thethree months ended March 31, 2024. The increase in the effective tax rate was primarily due to a nonrecurring tax benefit recognized in the prior period. The difference between statutory tax rates and our effective tax rate is primarily due to state and local taxes, partially offset by tax benefits attributable to equity compensation.

Current wording

The provision for income taxes was $74.6 million and the effective tax rate was 22.7% for thethree months ended June 30, 2025, compared to $85.2 million and 21.7% for thethree months ended June 30, 2024. The increase in the effective tax rate was primarily due to a nonrecurring tax benefit recognized in the prior period. The difference between statutory tax rates and our effective tax rate is primarily due to state and local taxes, partially offset by tax benefits attributable to equity compensation.

Previous wording

Our recent acquisition (Rocket within the claims category of the Insurance segment) and dispositions (AER within the underwriting category of our Insurance segment) resulted in a net decrease in revenue of $4.6 million, while the remaining Insurance revenues increased $53.6 million or 7.7%. Our underwriting revenue increased $38.5 million or 7.8%, primarily due to an annual increase in prices derived from continued enhancements to the models and content of the solutions within our forms, rules and loss cost services, as well as selling expanded solutions to new and existing customers within extreme event solutions. In addition, specialty business and life solutions contributed to the growth. Our claims revenue increased $15.1 million or 7.4%, primarily due to solid growth in anti-fraud solutions and property estimating solutions.

Current wording

Our recent acquisition (Rocket and Simplitium within the claims category of the Insurance segment) and dispositions (AER within the underwriting category of our Insurance segment) resulted in a net decrease in revenue of $8.4 million, while the remaining Insurance revenues increased $113.2 million or 8.0%. Our underwriting revenue increased $84.3 million or 8.5%, primarily due to an annual increase in prices derived from continued enhancements to the models and content of the solutions within our forms, rules and loss cost services, as well as selling expanded solutions to new and existing customers within extreme event solutions. In addition, specialty business and life solutions contributed to the growth. Our claims revenue increased $28.9 million or 7.0%, primarily due to solid growth in anti-fraud solutions and property estimating solutions.

Previous wording

As of March 31, 2025 and December 31, 2024, we had cash and cash equivalents and available-for-sale securities totaling $1,113.2 million and $292.5 million, respectively. We maintain our cash and cash equivalents in higher credit quality financial institutions in order to limit the amount of credit exposure. As of March 31, 2025 and December 31, 2024, a vast majority of our domestic cash and cash equivalents is with TD Bank, N.A., and JPMorgan Chase N.A. Subscriptions for our solutions are billed and generally paid in advance of rendering services either quarterly or in full upon commencement of the subscription period, which is usually for one year. Subscriptions are automatically renewed at the beginning of each calendar year. We have historically generated significant cash flows from operations. As a result of this factor, as well as the availability of funds under our Credit Facility, we expect that we will have sufficient cash to meet our working capital and capital expenditure needs and to fuel our future growth plans.

Current wording

As of June 30, 2025 and December 31, 2024, we had cash and cash equivalents and available-for-sale securities totaling $630.0 million and $292.5 million, respectively. We maintain our cash and cash equivalents in higher credit quality financial institutions in order to limit the amount of credit exposure. As of June 30, 2025 and December 31, 2024, a vast majority of our domestic cash and cash equivalents is with TD Bank, N.A., and JPMorgan Chase N.A. Subscriptions for our solutions are billed and generally paid in advance of rendering services either quarterly or in full upon commencement of the subscription period, which is usually for one year. Subscriptions are automatically renewed at the beginning of each calendar year. We have historically generated significant cash flows from operations. As a result of this factor, as well as the availability of funds under our Credit Facility, we expect that we will have sufficient cash to meet our working capital and capital expenditure needs and to fuel our future growth plans.

Previous wording

We have also historically used a portion of our cash for repurchases of our common stock from our stockholders. During thethree months ended March 31, 2025 and 2024, we repurchased $200.1 million (inclusive of $30.0 million in treasury stock not yet settled) and $200.0 million (inclusive of $30.0 million in treasury stock then not yet settled), respectively, of our common stock. The repurchase of our common stock in the first quarter of 2025 was funded using cash from operations. For thethree months ended March 31, 2025 and 2024, we also paid dividends of $63.0 million and $55.8 million, respectively.

Current wording

We have also historically used a portion of our cash for repurchases of our common stock from our stockholders. During the six months ended June 30, 2025 and 2024, we repurchased $300.1 million and $350.0 million (inclusive of $22.5 million in treasury stock then not yet settled), respectively, of our common stock. The repurchase of our common stock was funded using cash from operations. For the six months ended June 30, 2025 and 2024, we also paid dividends of $126.0 million and $111.3 million, respectively.

Previous wording

We had total debt, excluding finance lease liabilities, unamortized discounts and premium, and debt issuance costs of $3,750.0 million and $3,050.0 million at March 31, 2025 and December 31, 2024, respectively, and we were in compliance with our financial and other covenants. The debt at March 31, 2025, primarily consists of senior notes issued in 2025, 2024, 2023, 2020, 2019, and 2015. Interest on the senior notes is payable semi-annually each year. The unamortized discount and debt issuance costs were recorded as "Long-term debt" in the accompanying consolidated balance sheets, and will be amortized to "Interest expense" in the accompanying consolidated statements of operations within this Form 10-Q over the life of the respective senior note. The indenture governing the senior notes restricts our ability to, among other things, create certain liens, enter into sale/leaseback transactions, and consolidate with, sell, lease, convey, or otherwise transfer all or substantially all of our assets, or merge with or into, any other person or entity. We have made, and may from time to time in the future make, optional repayments on our debt obligations, which may include repurchases or exchanges of our outstanding notes, depending on various factors, such as market conditions. Any such repurchases may be effected through privately negotiated transactions, market transactions, tender offers, redemptions or otherwise. See Note 9. for additional information on our financing activities.

Current wording

We had total debt, excluding finance lease liabilities, unamortized discounts and premium, and debt issuance costs of $3,250.0 million and $3,050.0 million at June 30, 2025 and December 31, 2024, respectively, and we were in compliance with our financial and other covenants. The debt at June 30, 2025, primarily consists of senior notes issued in 2025, 2024, 2023, 2020, 2019, and 2015. Interest on the senior notes is payable semi-annually each year. The unamortized discount and debt issuance costs were recorded as "Long-term debt" in the accompanying consolidated balance sheets, and will be amortized to "Interest expense" in the accompanying consolidated statements of operations within this Form 10-Q over the life of the respective senior note. The indenture governing the senior notes restricts our ability to, among other things, create certain liens, enter into sale/leaseback transactions, and consolidate with, sell, lease, convey, or otherwise transfer all or substantially all of our assets, or merge with or into, any other person or entity. We have made, and may from time to time in the future make, optional repayments on our debt obligations, which may include repurchases or exchanges of our outstanding notes, depending on various factors, such as market conditions. Any such repurchases may be effected through privately negotiated transactions, market transactions, tender offers, redemptions or otherwise. See Note 9. for additional information on our financing activities.

Previous wording

We have a $1,000 million Syndicated Revolving Credit Facility with Bank of America N.A., HSBC Bank USA, N.A., JP Morgan Chase Bank, N.A., Wells Fargo Bank, N.A., Citibank, N.A., Morgan Stanley Bank, N.A., TD Bank, N.A., Goldman Sachs Bank USA, and the Northern Trust Company with a maturity date of April 5, 2028. Borrowing under the facility is payable at an interest rate of SOFR plus 100.0 to 162.5 basis points, depending on the public debt rating. The financial covenants require that, at the end of any fiscal quarter, we have a consolidated funded debt leverage ratio of less than 3.75 to 1.0*.* At our election, the maximum consolidated funded debt leverage ratio could be permitted to increase to 4.50 to 1.0 (no more than once) and to 4.25 to 1.0 (no more than once) in connection with the closing of a permitted acquisition. The Syndicated Credit Facility may be used for general corporate purposes, including working capital needs and capital expenditures, acquisitions, dividend payments, and the Repurchase Program. As of March 31, 2025, we were in compliance with all financial and other debt covenants under the Syndicated Credit Facility. As of March 31, 2025 and December 31, 2024, the available capacity under the Syndicated Revolving Credit Facility was $995.4 million, which takes into account outstanding letters of credit of $4.6 million.

Current wording

We have a $1,000.0 million Syndicated Revolving Credit Facility with Bank of America N.A., HSBC Bank USA, N.A., JP Morgan Chase Bank, N.A., Wells Fargo Bank, N.A., Citibank, N.A., Morgan Stanley Bank, N.A., TD Bank, N.A., Goldman Sachs Bank USA, and the Northern Trust Company with a maturity date of April 5, 2028. Borrowing under the facility is payable at an interest rate of SOFR plus 100.0 to 162.5 basis points, depending on the public debt rating. The financial covenants require that, at the end of any fiscal quarter, we have a consolidated funded debt leverage ratio of less than 3.75 to 1.0*.* At our election, the maximum consolidated funded debt leverage ratio could be permitted to increase to 4.50 to 1.0 (no more than once) and to 4.25 to 1.0 (no more than once) in connection with the closing of a permitted acquisition. The Syndicated Credit Facility may be used for general corporate purposes, including working capital needs and capital expenditures, acquisitions, dividend payments, and the Repurchase Program. As of June 30, 2025, we were in compliance with all financial and other debt covenants under the Syndicated Credit Facility. As of June 30, 2025 and December 31, 2024, the available capacity under the Syndicated Revolving Credit Facility was $995.4 million, which takes into account outstanding letters of credit of $4.6 million.

Previous wording

Net cash provided by operating activities was$444.7 million for thethree months ended March 31, 2025, compared to$372.2 million for thethree months ended March 31, 2024, an increase of$72.5 million or 19.5%. The increase in operating cash flow was due to an increase in operating profit and a federal tax refund received in the quarter, partially offset by the timing of certain cash payments throughout the quarter.

Current wording

Net cash provided by operating activities was$244.5 million for thethree months ended June 30, 2025, compared to$211.7 million for thethree months ended June 30, 2024, an increase of$32.8 million or 15.5%. The increase in operating cash flow was due to an increase in operating profit partially offset by the timing of certain cash payments throughout the quarter.

Previous wording

Net cash used in investing activities of$57.8 million for thethree months ended March 31, 2025 wasprimarily related to capital expenditures of$53.7 million, and a purchase of an additional controlling interest of $4.1 million. Net cash used in investing activities of$79.9 million for thethree months ended March 31, 2024 wasprimarily related to capital expenditures of $55.2 million, acquisitions and a purchase of an additional controlling interest of $25.9 million, and investments in nonpublic companies of $1.3 million.

Current wording

Net cash used in investing activities of$138.4 million for the six months ended June 30, 2025 was primarily related to capital expenditures of$109.5 million and an acquisition and purchase of an additional controlling interest of $24.4 million. Net cash used in investing activities of$23.8 million for the six months ended June 30, 2024 was primarily related to capital expenditures of $113.0 million, and acquisitions and a purchase of an additional controlling interest totaling $23.4 million, partially offset by proceeds received upon settlement of our retained interests related to the prior sales of our healthcare business in 2016 and our specialized markets business in 2022 of $112.1 million.

Previous wording

Net cash provided by financing activities of$433.3 million for thethree months ended March 31, 2025 was primarily driven by the net proceeds received from the issuance of long-term debt of $698.3 million and proceeds from stock options exercised of $24.7 million, partially offset by the funding of a $200.0 million accelerated share repurchase program, dividends paid of $63.0 million, the net share settlement of taxes from restricted stock and performance share awards of $17.9 million, and debt issuance costs of $6.2 million. Net cash used in financing activities of $242.5 million for thethree months ended March 31, 2024 was primarily driven by the funding of a $200.0 million accelerated share repurchase program, and dividends paid of $55.8 million, partially offset by proceeds from stock options exercised of $28.2 million.

Current wording

Net cash used in financing activities of$659.0 million for thethree months ended June 30, 2025 was primarily driven by the repayment of our 2025 senior note of $500.0 million, repurchases of common stock of $100.0 million, dividends paid of $63.0 million, payment of excise tax of $7.6 million, the net share settlement of taxes from restricted stock and performance share awards of $7.6 million, and other financing activities of $3.7 million, partially offset by the proceeds from stock options exercised of $22.9 million. Net cash provided by financing activities of$14.1 million for thethree months ended June 30, 2024 was primarily driven by the payment on early extinguishment of debt of $396.4 million, the funding of a $150.0 million accelerated share repurchase program, and dividends paid of $55.5 million, partially offset by proceeds from the issuance of long-term debt, net of original discount, of $590.2 million, and proceeds from stock options exercised of $35.0 million.
Rearranged current paragraphs (5)

Current report — wording carried from elsewhere

Our recent acquisition (Simplitium within the claims category of the Insurance segment) and dispositions (Atmospheric and Environmental Research ('AER') within the underwriting category of our Insurance segment) resulted in a net decrease in revenue of $3.8 million, while the remaining Insurance revenues increased $59.6 million or 8.4%. Our underwriting revenue increased $45.9 million or 9.1%, primarily due to an annual increase in prices derived from continued enhancements to the models and content of the solutions within our forms, rules and loss cost services, as well as selling expanded solutions to new and existing customers within extreme event solutions. In addition, specialty business and life solutions contributed to the growth. Our claims revenue increased $13.7 million or 6.6%, primarily due to solid growth in anti-fraud solutions and property estimating solutions.

Current report — wording carried from elsewhere

Our revenue by category for the periods presented is set forth below:

Current report — wording carried from elsewhere

Depreciation and Amortization of Fixed Assets

Current report — wording carried from elsewhere

The provision for income taxes was $138.7 million and the effective tax rate was 22.2% for thesix months ended June 30, 2025, compared to $141.0 million and 21.1% for thesix months ended June 30, 2024. The increase in the effective tax rate was primarily due to a nonrecurring tax benefit recognized in the prior period. The difference between statutory tax rates and our effective tax rate is primarily due to state and local taxes, partially offset by tax benefits attributable to equity compensation.

Current report — wording carried from elsewhere

Net cash provided by operating activities was$689.2 million for the six months ended June 30, 2025, compared to$592.4 million for the six months ended June 30, 2024, an increase of$96.8 million or 16.3%. The increase in operating cash flow was due to an increase in operating profit and a federal tax refund received in the first quarter of 2025.